Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
A observational or N/A phase clinical study on Lung Inflammation and Polymorphism, this trial is completed. The trial is conducted by National Institute of Environmental Health Sciences (NIEHS) and has accumulated 42 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Study Description(click to expand)This is a prospective, cross-sectional study designed to provide a consistent method for obtaining biological samples and respiratory health-related information from participants for use in research that evaluates lung function (e.g., responses to environmental agents such as air pollution particles, engineered nanomaterials, or immune ligands; the role of genetics on cellular responses or functioning). Study participants will be adult volunteers, ages 18-65 (inclusive), who meet eligibility criteria to undergo bronchoscopy. Potential participants will be prescreened and scheduled for a final eligibility visit that will include medical history review, vital signs, physical examination, blood draw, and pulmonary function tests. After eligibility is confirmed, the participant will be scheduled for biological sample collections, which will include a blood draw and bronchoscopy. The objective of this protocol is to investigate the role of cytochrome P450 (CYP) epoxygenase pathway enzymes, including the soluble epoxide hydrolase (sEH; encoded by EPHX2) and CYP2J2 proteins, in macrophage function and inflammatory responses. The primary outcome measure will evaluate macrophage phagocytosis in an ex vivo assay, comparing groups of individuals with and without EPHX2 and CYP2J2 polymorphisms of interest. Secondary outcomes will include evaluations of ex vivo gene expression of inflammatory receptors and cytokines in stimulated macrophages (alveolar and...
This is a prospective, cross-sectional study designed to provide a consistent method for obtaining biological samples and respiratory health-related information from participants for use in research that evaluates lung function (e.g., responses to environmental agents such as air pollution particles, engineered nanomaterials, or immune ligands; the role of genetics on cellular responses or functioning).
Study participants will be adult volunteers, ages 18-65 (inclusive), who meet eligibility criteria to undergo bronchoscopy. Potential participants will be prescreened and scheduled for a final eligibility visit that will include medical history review, vital signs, physical examination, blood draw, and pulmonary function tests. After eligibility is confirmed, the participant will be scheduled for biological sample collections, which will include a blood draw and bronchoscopy.
The objective of this protocol is to investigate the role of cytochrome P450 (CYP) epoxygenase pathway enzymes, including the soluble epoxide hydrolase (sEH; encoded by EPHX2) and CYP2J2 proteins, in macrophage function and inflammatory responses. The primary outcome measure will evaluate macrophage phagocytosis in an ex vivo assay, comparing groups of individuals with and without EPHX2 and CYP2J2 polymorphisms of interest. Secondary outcomes will include evaluations of ex vivo gene expression of inflammatory receptors and cytokines in stimulated macrophages (alveolar and peripheral blood monocyte-derived), assessment of the lower airway microbiome from bronchoalveolar lavage (BAL) fluid, and measurement of eicosanoids and cytokines in serum and BAL fluid.
Status Flow
Change History
42 versions recorded-
May 4, 2026 — Present [daily]
Completed
-
Apr 28, 2026 — May 4, 2026 [daily]
Completed
-
Feb 2026 — Apr 2026 [monthly]
Completed
-
Jan 2026 — Feb 2026 [monthly]
Completed
-
Dec 2025 — Jan 2026 [monthly]
Completed
▶ Show 37 earlier versions
-
Oct 2025 — Dec 2025 [monthly]
Completed
-
Sep 2025 — Oct 2025 [monthly]
Completed
-
Jul 2025 — Sep 2025 [monthly]
Completed
-
Apr 2025 — Jul 2025 [monthly]
Completed
-
Nov 2024 — Apr 2025 [monthly]
Completed
-
Oct 2024 — Nov 2024 [monthly]
Completed
-
Sep 2024 — Oct 2024 [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
-
Jul 2024 — Aug 2024 [monthly]
Completed
-
Oct 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Nov 2022 — Oct 2023 [monthly]
Recruiting
Status: Enrolling By Invitation → Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Enrolling By Invitation
-
Jul 2022 — Sep 2022 [monthly]
Enrolling By Invitation
-
Jun 2022 — Jul 2022 [monthly]
Enrolling By Invitation
-
May 2022 — Jun 2022 [monthly]
Enrolling By Invitation
-
Apr 2022 — May 2022 [monthly]
Enrolling By Invitation
-
Jan 2022 — Apr 2022 [monthly]
Enrolling By Invitation
-
Dec 2021 — Jan 2022 [monthly]
Enrolling By Invitation
-
Sep 2021 — Dec 2021 [monthly]
Enrolling By Invitation
-
Mar 2021 — Sep 2021 [monthly]
Enrolling By Invitation
-
Jan 2021 — Mar 2021 [monthly]
Enrolling By Invitation
-
Mar 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
Feb 2020 — Mar 2020 [monthly]
Enrolling By Invitation
-
Sep 2019 — Feb 2020 [monthly]
Enrolling By Invitation
-
Jul 2019 — Sep 2019 [monthly]
Enrolling By Invitation
-
May 2019 — Jul 2019 [monthly]
Enrolling By Invitation
-
Mar 2019 — May 2019 [monthly]
Enrolling By Invitation
-
Feb 2019 — Mar 2019 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Dec 2018 — Feb 2019 [monthly]
Not Yet Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Not Yet Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Not Yet Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
May 2017 — Jun 2017 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
Background: Respiratory diseases affect more than 1 billion people worldwide. They are a growing public health concern. The lungs are constantly exposed to environmental factors such as dust, fumes, microbes, and pollutants. But much is still not known about how these pollutants lead to respiratory illnesses. Researchers want to collect samples from lungs and blood to see how genetics and environmental pollutants affect cellular responses or functioning. Objectives: To study how cytochrome P450 epoxygenase pathway enzymes affect macrophage function in the lungs and inflammatory responses. Eligibility: Adults ages 18 65 who can have a bronchoscopy. Design: All study visits will take place at the NIEHS Clinical Research Unit in Research Triangle Park, NC. At study visit 1, participants will be screened with medical history and physical exam. They will have blood and urine tests. They will take tests that measure their lung function. They will answer questionnaires. Before the visit, they will be given a list of medicines they cannot take. They also must not have caffeine on the day of their visit. The visit will last about 3 hours. At study visit 2, participants will give blood samples. They will undergo bronchoscopy. For this, they will get an intravenous line in a vein to get sedatives. Their airways will be numbed. Cells will be collected from their lungs. They will fast for 8 hours before the visit. They must have someone else drive them home from the visit. The visit will last about 3-4 hours. Participants will get a follow-up phone call about 1 day after study visit 2.
Contact Information
- National Institute of Environmental Health Sciences (NIEHS)
For direct contact, visit the study record on ClinicalTrials.gov .